Demoted from her tenure track position in the mid 90s, Katalin Karikó persisted with her research into RNA therapeutics and is now senior vice president of BioNtech.
Results for "COVID-19 vaccines"
New macrocycle antiviral drugs show promise in treating influenza
Creating antiviral drugs to help treat infected patients is more important than ever. Now, researchers report a non-toxic macrocycle antiviral agent that shows high efficacy against several influenza strains.
Pfizer/BioNTech vaccine approved in the UK for immediate emergency use
The companies announce the first emergency approval of their mRNA vaccine against COVID-19, with rollout to begin next week.
The cost of chaos: If we can’t control quantity, we’d better control quality
Freeness of scientific literature is undeniably a highly desirable concept, but it is accompanied by a responsibility that we have not yet structurally realized.
Lipid nanoparticles boost potential vaccine against SARS-CoV-2
Researchers enhance the immune response against the receptor binding domain of SARS-CoV-2 by presenting it on liposomes, providing a promising strategy for vaccine development targeting this domain.
Nasal vaccine against SARS-CoV-2 prevents infection and spread throughout the body
Study claims nasal delivery protects first site of infection and produces widespread immune response compared to intramuscular injection.
Syringe technology could enable injection of concentrated biologic drugs
Researchers have designed a simple, low-cost device for subcutaneous injection of viscous formulations.
Challenges in vaccine development during an evolving pandemic
As researchers race to produce the long-awaited SARS-CoV-2 vaccine, the global scale of this pandemic is posing some unique hurdles.
Human-on-a-chip provides an accurate model for the immune system
A new in vitro model of the body’s immune system better predicts its response to new therapeutics, potentially lowering the high costs and low success rates of drug discovery.
Twin antibodies show neutralizing activity against SARS-CoV-2
Scientists identify a cocktail of antibodies from a recovered COVID-19 patient’s blood sample that helped neutralize the SARS-CoV-2 virus in mice.
Popular
-
Quantum entanglement visualized for the first time ever
-
Tiny robots with a big impact: Scientists develop microrobots for single-cell handling
-
Springer Nature staff to take unprecedented strike action
-
An anti-inflammatory peptide may hold the key to low-back pain relief
-
Gliese 12 b: An exo-Venus with Earth-like temperatures
-
Could a nuclear explosion set Earth’s atmosphere on fire?
-
How the brain protects itself from the negative effects of CBD
-
New study reveals surprising impact of screen time on the developing brain
-
String theory provides a new take on the expansion of the Universe
-
Contact lenses bring 3D holograms to life for augmented reality